Physician

Kimberly Ann Lehman, D.O.

According to 2025 Medicare claims, Kimberly Lehman, D.O. (NPI: 1932320397) practices dermatology in the Clarksville, TN-KY market, with the plurality of this provider's patient population coming from Montgomery, TN. This provider's primary affiliated billing organization is CUMBERLAND SKIN SURGERY AND DERMATOLOGY (NPI: 1922138247; TIN: 20-8555616) and primary practice location at 37043-8948.

Lehman's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 803 traditional Medicare patients, billed 6,221 HCPCS/CPT codes, and received $185,251 in Medicare payments. The top billing code was 17110 (Destruction of skin growth, 1-14 growths). Part D data shows 764 prescription claims across 305 beneficiaries totaling $147,197 in drug costs, led by Otezla (Apremilast). Open Payments data shows 81 records totaling $1,669. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved up and down with repeated peaks and valleys, starting at $207,820 and ending at $185,251. Concurrently, Part D prescription costs have moved from a lower plateau to a higher plateau, from $81,066 to $147,197. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$217K$434K2015 Medicare payment: $207,820 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $138,963 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $153,530 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $201,419 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $224,651 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $210,359 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $434,289 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $214,281 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $198,434 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $185,251 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20159456,818$207,820
20165574,466$138,963
20176095,118$153,530
20188026,578$201,419
20198667,690$224,651
20209086,697$210,359
20219147,873$434,289
20228326,995$214,281
20238146,450$198,434
20248036,221$185,251

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$116K$232K2015 Drug cost: $81,066 (USD; Tot_Drug_Cst)2016 Drug cost: $43,992 (USD; Tot_Drug_Cst)2017 Drug cost: $46,930 (USD; Tot_Drug_Cst)2018 Drug cost: $81,106 (USD; Tot_Drug_Cst)2019 Drug cost: $59,644 (USD; Tot_Drug_Cst)2020 Drug cost: $128,969 (USD; Tot_Drug_Cst)2021 Drug cost: $197,820 (USD; Tot_Drug_Cst)2022 Drug cost: $165,610 (USD; Tot_Drug_Cst)2023 Drug cost: $231,857 (USD; Tot_Drug_Cst)2024 Drug cost: $147,197 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015230585$81,066
2016191459$43,992
2017159385$46,930
2018212508$81,106
2019226546$59,644
2020242634$128,969
2021302762$197,820
2022267643$165,610
2023249647$231,857
2024305764$147,197

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
17110Destruction of skin growth, 1-14 growths407569$71
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more675953$55
11102Biopsy of related skin growth, first growth287371$50
17000Destruction of precancer skin growth, 1 growth447742$30
17003Destruction of precancer skin growth, 2-14 growths3522,852$4

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
OtezlaApremilast11330$52,240
Clobetasol PropionateClobetasol Propionate812,391$5,479
KetoconazoleKetoconazole1013,640$1,910
FluorouracilFluorouracil27747$1,884
MetronidazoleMetronidazole381,109$1,548

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.81$1,669SUN PHARMACEUTICAL INDUSTRIES INC.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Kimberly Ann Lehman, D.O.?

Tedicare shows public-source Medicare data for Kimberly Ann Lehman, D.O. (NPI 1932320397), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Kimberly Ann Lehman, D.O. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Kimberly Ann Lehman, D.O.?

Kimberly Ann Lehman, D.O. is linked to CUMBERLAND SKIN SURGERY AND DERMATOLOGY (billing NPI 1922138247) in the available physician profile data.

Does Kimberly Ann Lehman, D.O. have Open Payments data?

Kimberly Ann Lehman, D.O. has 81 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.